- CLIR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
ClearSign Technologies (CLIR) S-1/AIPO registration (amended)
Filed: 27 Nov 17, 12:00am
| Washington | | | 3823 | | | 26-2056298 | |
| (State or other jurisdiction of incorporation or organization) | | | (Primary Standard Industrial Classification Code Number) | | | (I.R.S. Employer Identification No.) | |
| Sonya Erickson Alan Hambelton Cooley LLP 1700 Seventh Avenue Suite 1900 Seattle, Washington 98101 (206) 452-8700 | | | Joseph Smith Robert Charron Michael Nertney Ellenoff Grossman & Schole LLP 1345 Avenue of the Americas New York, New York 10105 (212) 370-1300 | |
| Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| Non-accelerated filer ☐ | | | Smaller reporting company ☒ | |
| (Do not check if a smaller reporting company) | | | Emerging growth company ☒ | |
| | | Per Share and Related Warrant | | | Total | | ||||||
Public offering price(1) | | | | $ | | | | | $ | | | ||
Underwriting discounts and commissions(2)(3) | | | | $ | | | | | | $ | | | |
Proceeds to us (before expenses) | | | | $ | | | | | | $ | | | |
| | | Page | | |||
| | | | 1 | | | |
| | | | 8 | | | |
| | | | 16 | | | |
| | | | 17 | | | |
| | | | 18 | | | |
| | | | 19 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 23 | | | |
| | | | 32 | | | |
| | | | 38 | | | |
| | | | 40 | | | |
| | | | 40 | | | |
| | | | 41 | | | |
| | | | 41 | | | |
| | | | 42 | | |
| ![]() | | | ![]() | |
| ![]() | | | ![]() | |
| Non-attainment areas under the 1997 limit of 84 ppb Source: EPA, August 2016 | | | Projected non-attainment areas under the 2015 limit of 70 ppb Source: URS, August 2015 | |
| | | For the Years Ended December 31, | | | For the Nine Months Ended September 30, (unaudited) | | ||||||||||||||||||
| | | 2016 | | | 2015 | | | 2017 | | | 2016 | | ||||||||||||
Sales | | | | $ | 621,000 | | | | | $ | 61,000 | | | | | $ | 360,000 | | | | | $ | 260,000 | | |
Cost of goods sold | | | | | 485,000 | | | | | | 50,000 | | | | | | 266,000 | | | | | | 47,000 | | |
Gross profit | | | | | 136,000 | | | | | | 11,000 | | | | | | 94,000 | | | | | | 213,000 | | |
Operating Expenses: | | | | | | ||||||||||||||||||||
Research and Development | | | | | 4,831,000 | | | | | | 2,932,000 | | | | | | 3,644,000 | | | | | | 3,767,000 | | |
General and Administrative | | | | | 6,510,000 | | | | | | 5,021,000 | | | | | | 3,569,000 | | | | | | 5,342,000 | | |
Total Operating Expenses | | | | | 11,341,000 | | | | | | 7,953,000 | | | | | | 7,213,000 | | | | | | 9,109,000 | | |
Other Income | | | | | 32,000 | | | | | | 44,000 | | | | | | 32,000 | | | | | | 30,000 | | |
Net loss | | | | $ | (11,173,000) | | | | | $ | (7,898,000) | | | | | $ | (7,087,000) | | | | | $ | (8,866,000) | | |
Net loss per common share, basic and diluted | | | | $ | (0.86) | | | | | $ | (0.63) | | | | | $ | (0.46) | | | | | $ | (0.69) | | |
Weighted average common shares outstanding, basic and diluted | | | | | 12,928,715 | | | | | | 12,461,515 | | | | | | 15,358,655 | | | | | | 12,914,665 | | |
|
| | | December 31 | | | September 30, 2017 | | ||||||||||||
| | | 2016 | | | 2015 | | ||||||||||||
Working capital | | | | $ | 355,000 | | | | | $ | 9,564,000 | | | | | $ | 2,691,000 | | |
Total assets | | | | | 3,786,000 | | | | | | 14,202,000 | | | | | | 6,612,000 | | |
Cash and cash equivalents | | | | | 1,259,000 | | | | | | 10,985,000 | | | | | | 3,511,000 | | |
Total shareholders’ equity | | | | | 2,244,000 | | | | | | 12,578,000 | | | | | | 4,856,000 | | |
| | | Price Ranges | | |||||||||
| | | High | | | Low | | ||||||
Fiscal Year Ended December 31, 2017 (through November 20, 2017) | | | | ||||||||||
First Quarter | | | | $ | 4.55 | | | | | $ | 3.05 | | |
Second Quarter | | | | | 4.25 | | | | | | 3.30 | | |
Third Quarter | | | | | 4.00 | | | | | | 2.90 | | |
Fourth Quarter | | | | | 3.55 | | | | | | 2.45 | | |
Fiscal Year Ended December 31, 2016 | | | | ||||||||||
First Quarter | | | | $ | 4.90 | | | | | $ | 2.98 | | |
Second Quarter | | | | | 5.28 | | | | | | 3.75 | | |
Third Quarter | | | | | 6.09 | | | | | | 4.14 | | |
Fourth Quarter | | | | | 6.08 | | | | | | 3.40 | | |
Fiscal Year Ended December 31, 2015 | | | | ||||||||||
First Quarter | | | | $ | 7.62 | | | | | $ | 4.97 | | |
Second Quarter | | | | | 5.90 | | | | | | 4.74 | | |
Third Quarter | | | | | 7.23 | | | | | | 3.44 | | |
Fourth Quarter | | | | | 6.41 | | | | | | 4.44 | | |
| | | As of September 30, 2017 | | | |||||||||||
| | | (in thousands, except per share data) | | | |||||||||||
| | | Actual(1) | | | As Adjusted(2) | | | ||||||||
| | | (unaudited) | | | | ||||||||||
Cash and cash equivalents | | | | $ | 3,511 | | | | | $ | 12,564 | | | | ||
Shareholders’ equity: | | | | | ||||||||||||
Common stock, par value $0.0001 per share: 62,500,000 shares of common stock authorized; 15,606,353 issued and outstanding at September 30, 2017, actual; 62,500,000 shares of common stock authorized; 19,006,353 issued and outstanding, as adjusted | | | | | 2 | | | | | | 2 | | | | ||
Additional paid in capital | | | | | 52,272 | | | | | | 61,325 | | | | ||
Accumulated deficit | | | | | (47,418) | | | | | | (47,418) | | | | | |
Total shareholders’ equity | | | | $ | 4,856 | | | | | $ | 13,909 | | | | ||
Total capitalization | | | | $ | 6,612 | | | | | $ | 15,665 | | | | ||
|
| Assumed combined public offering price per share and related warrant | | | | | | | | | | $ | 2.95 | | |
| Net tangible book value per share as of September 30, 2017 | | | | $ | 0.19 | | | | | | | | |
| Increase per share attributable to new investors in this offering | | | | $ | 0.45 | | | | |||||
| Adjusted net tangible book value per share after this offering | | | | | | | | | | $ | 0.64 | | |
| Dilution in net tangible book value per share to new investors | | | | | | | | | | $ | 2.31 | | |
| ![]() | | | ![]() | |
| Non-attainment areas under the 1997 limit of 84 ppb Source: EPA, August 2016 | | | Projected non-attainment areas under the 2015 limit of 70 ppb Source: URS, August 2015 | |
Underwriter | | | Number of Shares | | | Number of Warrants | | ||||||
Ladenburg Thalmann & Co. Inc. | | | | | | | | | | | | | |
Total | | | | | | | | | | | | ||
|
| | | Per Share(1) | | | Per Warrant(1) | | | Total(1) | |
Public offering price | | | | | ||||||
Underwriting discount to be paid to the underwriters by us (7.0%)(2) | | | | | ||||||
Proceeds to us (before expenses) | | | | |
| SEC Filing Fee | | | | $ | 2,864 | | |
| FINRA Fee | | | | $ | 3,950 | | |
| Printing Expenses* | | | | $ | 15,000 | | |
| Accounting Fees and Expenses* | | | | $ | 15,000 | | |
| Legal Fees and Expenses* | | | | $ | 225,000 | | |
| Transfer Agent and Registrar Expenses* | | | | $ | 5,000 | | |
| Miscellaneous* | | | | $ | 8,186 | | |
| Total | | | | $ | 275,000 | | |
|
| | | | CLEARSIGN COMBUSTION CORPORATION | | |||
| | | | By: | | | /s/ Stephen E. Pirnat | |
| | | | | | | Stephen E. Pirnat | |
| | | | | | | Chief Executive Officer | |
| Dated: November 27, 2017 | | | /s/ Stephen E. Pirnat | |
| | | | Stephen E. Pirnat | |
| | | | Chief Executive Officer and Director | |
| | | | ||
| Dated: November 27, 2017 | | | /s/ Brian G. Fike | |
| | | | Brian G. Fike | |
| | | | Interim Chief Financial Officer | |
| | | | ||
| Dated: November 27, 2017 | | | * | |
| | | | Jeffrey L. Ott, Director | |
| | | | ||
| Dated: November 27, 2017 | | | * | |
| | | | Scott P. Isaacson, Director | |
| | | | ||
| Dated: November 27, 2017 | | | * | |
| | | | Lon E. Bell, Ph.D., Director | |
| *By: | | | /s/ Stephen E. Pirnat Stephen E. Pirnat Attorney-in-fact | |